CPPs-nanoparticles | CPPs | CPPs Sequence | Ligand | Nanoparticles | Cargos | Cell model | Animal model | Therapeutic use | Refs. |
---|---|---|---|---|---|---|---|---|---|
TGN-NP | TGN | TGNYKALHPHNG |  – | PEG-PLGA nanoparticles |  – | bEnd.3 | Nude mice, ICR mice | Glioma | [182] |
AsTNP | TGN | TGNYKALHPHNG | AS1411 | PEG-PCL nanoparticles | Docetaxel | C6, bEnd.3 | C6 bearing mice | Glioma | [141] |
Tf-PFV-Lip | PFV | PFVYLI | Tf | Liposomes | Doxorubicin, Erlotinib | In vitro BBB model, 3D tumor model | – | Glioma | [183] |
ILNPs | IL-13p | TAMRAVDKLLLHLKKLFREGQFNRNFESIIICRDRT |  – | Liposomes | Docetaxel | U87, HUVEC, 3D tumor model | U87 bearing mice | Glioma | [140] |
cFd-Lip | dNP2 | KIKKVKKKGRKKIKKVKKKGRK-cys | Folic acid (FA) | Liposomes | Paclitaxel | 4T1, NIH 3T3, bEnd.3, 3D tumor model | Breast tumor bearing mice, breast cancer brain metastasis models | Breast cancer and brain metastasis | [184] |
cFd-Lip | dNP2 | KIKKVKKKGRKKIKKVKKKGRK-cys | FA | Liposomes | Paclitaxel | bEnd.3, C6 | C6 bearing mice | Glioma | [185] |
MT1-NP | MT1-AF7p | HWKHLHNTKTFLC | iRGD | PEG-PLA nanoparticles | Paclitaxel | C6 | C6 bearing mice | Glioma | [186] |
CNP, ANP | CPP, ACPP | CRRRRRRRRR, EEEEEEEEC6GSGRSAGRRRRRRRRC6C |  – | Nanoparticles | Paclitaxel | C6 | C6 bearing mice | Glioma | [187] |
DGL-PEG-LNP | NoLS | KKRTLRKNDRKKRC |  – | Nanoparticles | Plasmid DNA encoding inhibitor of growth 4 (ING4) | BCEC | U87 bearing mice | Glioma | [33] |
RGE-LS | RGERPPR | RGERPPR |  – | Liposomes | Doxorubicin | U87 | U87 bearing mice, | Glioma | [188] |
TBCNT@OXA | TAT |  YGRKKRRQRRR |  – | Carbon nanotube | Oxaliplatin | HBMEC, C6 | C6 bearing mice | Glioma | [189] |
TR-Lip | TR | c(RGDfK)- AGYLLGHINLHHLAHL(Aib)HHIL-Cys |  – | Liposomes | Paclitaxel | C6, bEnd.3, CSCs | C6 bearing mice | Glioma | [190] |
RGE-PEG / PGG-PTX NPs | RGERPPR | RGERPPR |  – | Nanoparticles | polymer-drug conjugates (PGG-PTX) | U87, HUVECs | U87 bearing mice | Glioma | [191] |
pSiNPs | SIWV | SIWV |  – | Nanoparticles | SN-38 | U87 | U87 bearing mice | Glioma | [192] |
Tf-Pen lip | Pen | RQIKIWFQNRRMKWKK | Tf | Liposomes | Doxorubicin, Erlotinib | U87, bEnd.3 | U87 bearing mice | Glioma | [193] |
Tf-Pen lip | Pen | RQIKIWFQNRRMKWKK | Tf | Liposomes | 5-Fluorouracil | U87, bEnd.3 | U87 bearing mice | Glioma | [194] |
iNGR-SSL | iNGR | CC(Acm)RNGRGPDC(Acm) |  – | Liposomes | Doxorubicin | U87, HUVECs | U87 bearing mice | Glioma | [195] |
P1NS/TNC-FeLP | P1NS | Cys-GRKKRRQRRRPQ | TN-C | Thermosensitive liposomal | Doxorubicin | bEnd.3, CRL-2299, C8-D1A, CRL-2541, U87, HTB-14 | - | Glioma | [196] |
TF-CPP-SSL | CPP | GGRRRRRRRRR-amide | Tf | Liposome | Doxorubicin | C6, HUVECs | C6 bearing mice | Glioma | [197] |